153
Participants
Start Date
July 31, 2016
Primary Completion Date
April 8, 2020
Study Completion Date
April 8, 2020
SRA737, gemcitabine, cisplatin
SRA737, gemcitabine
START Madrid, Madrid
Hospital Universitario 12 de Octobre, Madrid
Hospital Universitario Virgen de la Victoria, Málaga
Biomedical Research Institute INCLIVA, Valencia
Hospital Universitario Vall d'Hebron, Barcelona
Hospital Clinic de Barcelona, Barcelona
Royal Marsden Hospital, Sutton
Belfast City Hospital, Belfast
Oxford University Hospitals, Headington
Velindre Cancer Centre, Cardiff
The Clatterbridge Cancer Centre, Bebington
The Beatson West of Scotland Cancer Centre, Glasgow
Leeds Teaching Hospital of St James University Hospital, Leeds
University Hospital of Leceister NHS TRUST, Leicester
Guy's and St Thomas', London
Sarah Cannon Research Institute, London
University College London, London
The Christie NHS Foundation Trust, Manchester
Freeman Hospital, Newcastle upon Tyne
Sheffield Teaching Hospitals, Sheffield
Sierra Oncology LLC - a GSK company
INDUSTRY